Analysts fell to the sidelines weighing in on Fortis (FTS – Research Report), Callon (CPE – Research Report) and Ovintiv (OVV – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Fortis (FTS)
RBC Capital analyst Maurice Choy maintained a Hold rating on Fortis on July 30 and set a price target of C$59.00. The company’s shares closed last Friday at $45.34.
According to TipRanks.com, Choy is a 4-star analyst with an average return of
Currently, the analyst consensus on Fortis is a Hold with an average price target of $46.33, implying a 2.0% upside from current levels. In a report issued on July 18, J.P. Morgan also maintained a Hold rating on the stock with a C$58.00 price target.
See today’s analyst top recommended stocks >>
Callon (CPE)
In a report issued on July 28, Scott Hanold from RBC Capital maintained a Hold rating on Callon, with a price target of $54.00. The company’s shares closed last Friday at $39.36.
According to TipRanks.com, Hanold is a 3-star analyst with an average return of
Callon has an analyst consensus of Hold, with a price target consensus of $52.43, implying a 31.6% upside from current levels. In a report issued on July 19, Citigroup also maintained a Hold rating on the stock with a $45.00 price target.
Ovintiv (OVV)
RBC Capital analyst Gregory Pardy maintained a Hold rating on Ovintiv on July 28 and set a price target of $36.00. The company’s shares closed last Friday at $25.66.
According to TipRanks.com, Pardy is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Ovintiv with a $40.12 average price target, which is a 55.0% upside from current levels. In a report issued on July 20, Raymond James also initiated coverage with a Hold rating on the stock with a $35.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on FTS:
- Analysts Are Neutral on These Healthcare Stocks: Seagen (SGEN), Crispr Therapeutics AG (CRSP)
- Wall Street Analysts Are Bullish on Top Technology Picks
- Analysts Conflicted on These Conglomerates Names: Norfolk Southern (NSC), IDEX (IEX) and Fortune Brands (FBHS)
- Analysts Offer Insights on Materials Companies: Sherwin-Williams Company (SHW), West Fraser Timber Co (WFG) and Enviva (EVA)
- Analysts Offer Insights on Financial Companies: S&P Global (SPGI), Mastercard (MA) and Camden Property (CPT)